Abstract
Intracavernous injection of smooth muscle relaxing agents can induce penile erection. In this experimental study, we compared the effects of intracavernously injected calcium channel blockers (CCBs) and papaverine in dogs, and investigated their clinical applicabilities.
We administered 30 mg papaverine, 10 mg nifedipine, 10 mg nitrendipine and 2.5 mg verapamil to 10 adult male dogs intracavernously, each at different times. Intracavernous pressure values, systemic arterial pressure values and heart rate values were recorded for 45 minutes after the intracavernous injections. We used the paired Studentt-test for statistical analysis.
Papaverine induced full erection in all of the 10 dogs. Nifedipine induced full erection in 4, nitrendipine in 5, and verapamil in 6 of the 10 dogs. Nifedipine and nitrendipine caused significant decreases in blood pressure and increases in heart rate.
In conclusion, the effects of intracavernous CCBs are not superior to those of papaverine. We cannot recommend nifedipine and nitrendipine for intracavernous injection, but verapamil may be included in intracavernous pharmacotherapeutic combinations.
Similar content being viewed by others
References
Lue, T. F., Tanagho, E. A.: Physiology of erection and pharmacological management of impotence.J. Urol., 137, 829 (1987).
Fallon, B.: Intracavernous injection therapy for male erectile dysfunction.Urol. Clin. North Am., 22, 833 (1995).
Christ, G. J., Brink, P. R., Melman, A., Spray, D. C.: The role of gap junctions and ion channels in the modulation of electrical and chemical signals in human corpus cavernosum smooth muscle.Int. J. Impotence Res., 5, 77 (1993).
Martinez-Pineiro, L., Trigo-Rocha, F., Hsu, G. L., Von Heyden, B., Lue, T. F., Tanagho, E. A.: Cyclic guanosine monophosphate mediates penile erection in the cat.Eur. Urol., 24, 492 (1993).
Christ, G. J., Spray, D. C., Brink, P. R.: Characterization of K currents in cultured human corporal smooth muscle cells.J. Androl., 14, 319 (1993).
Christ, G. J.: The penis as a vascular organ (The importance of corporal smooth muscle tone in the control of erection).Urol. Clin. North Am., 22, 727 (1995).
Fovaeus, M., Andersson, K.-E., Hedlund, H.: Effects of some calcium channel blockers on isolated human penile erectile tissues.J. Urol., 138, 1267 (1987).
Kerfoot, W. W., Park, H. Y., Schwartz, L. B., Hagen, P.-O., Carson, C. C.: Characterization of calcium channel blocker induced smooth muscle relaxation using a model of isolated corpus cavernosum.J. Urol., 150, 249 (1993).
Cho, C.-K., Suh, J.-K., Chang, T.-G., Kim, Y.-S., Park, T.-C., Choi, H.-K.: Effect of calcium channel blockers on penile erection in vivo.J. Urol., 151, 321A (1994).
Goodman Gilman, A.: Pharmacological Basis of Therapeutics. Macmillan, New York 1990.
Vardi, Y., Siroky, M. B.: A canine model for hemodynamic study of isolated corpus cavernosum.J. Urol., 138, 663 (1987).
Azadzoi, K. M., Payton, T., Krane, R. J., Goldstein, I.: Effects of intracavernosal trazodone hydrochloride: Animal and human studies.J. Urol., 144, 1277 (1990).
Juenemann, K.-P., Lue, T. F., Fournier, G. R. Jr., Tanagho, E. A.: Hemodynamics of papaverine and phentolamine induced penile erection.J. Urol., 136, 158 (1986).
Van Ahlen, H., Peskar, B. A., Sticht, G., Hertfelder, H. J.: Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum.J. Urol., 151, 1227 (1994).
Lundberg, P. O., Biriell, C.: Impotence-the drug risk factor.Int. J. Impotence Res., 5, 237 (1993).
Haidl, G.: Effekt von Nitrendipin auf die vaskulär bedingte erektile Dysfunktion.Med-welt, 40, 1258 (1989).
Breza, J., Aboseif, S., Lue, T. F.: Anatomy of the penis.Atlas of the Urol. Clin. North Am., 1, 1 (1993).
Trigo-Rocha, F., Donatucci, C. F., Hsu, G. L., Nunes, L., Lue, T. F., Tanagho, E. A.: The effect of intracavernous injection of potassium channel openers in monkeys and dogs.Int. J. Impotence Res., 7, 41 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sarikaya, Ş., Aşçi, R., Aybek, Z. et al. Effects of intracavernous calcium channel blockers in dogs. International Urology and Nephrology 29, 673–680 (1997). https://doi.org/10.1007/BF02552185
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02552185